Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors.
Targeting ITGB4/SOX2-driven lung cancer stem cells using proteasome inhibitors. iScience. 2023 Aug 18; 26(8):107302.
View in:
PubMed
authors with profiles
Ravi Salgia